Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Diaronex
- Development stage
- Unknown
- Lead developer
- Innomane
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Diaronex is a natural health product developed by Innomane Inc. for the treatment of diarrhea. It is formulated from the bark extract of *Holarrhena pubescens* (also known as *Holarrhena antidysenterica*), a medicinal tree native to the Himalayan region with a long history of use in Ayurvedic medicine for gastrointestinal ailments. The product is approved by Health Canada and is available over-the-counter in tablet form. Diaronex functions by creating a protective barrier within the intestinal tract and acting directly against diarrhea-causing microorganisms. It is manufactured in a GMP-certified facility in Toronto and distributed through major Canadian retailers like Rexall.
- Brand names
- Diaronex
- Other names
- Holarrhena pubescens bark extractHolarrhena antidysenterica bark extract
Beyond the preview
Go deeper on Diaronex.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Diaronex.